First UKAS accreditation in molecular biology

Published: 6-Mar-2006 Featured companies: Almac Group
Analysis Pharmaceutical

Almac Diagnostics, a biotechnology company based in Northern Ireland, has become the first company to be awarded accreditation for gene expression microarray and bioinfomatics analysis by the United Kingdom Accreditation Service (UKAS).


Almac Diagnostics, a biotechnology company based in Northern Ireland, has become the first company to be awarded accreditation for gene expression microarray and bioinfomatics analysis by the United Kingdom Accreditation Service (UKAS).

Accreditation by UKAS demonstrates a high level of competence and capability and is important in the management of business risk.

Almac Diagnostics has achieved accreditation by UKAS to ISO/IEC 17025. The company specialises in the application of microarray technology to the diag-nosis and treatment of cancer, utilising the Affymetrix GeneChip platform.

  

Featured companies

See more

You may also like

Sustainability

Almac Group signs virtual power purchase agreement for renewable energy

Read more
The integration of renewable energy will cut the company’s global scope 2 carbon emissions by 46%

Trending Articles

  1. Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222 Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the vaccine candidate drug substance commencing late in the third quarter of 2020
  2. UPS Healthcare supports Irish pharma with novel Dublin facility The opening of the facility will expand the global connectivity of the Irish pharmaceutical market, which accounts for 50% of all national exports
  3. Indian government bans three medicines owing to health risks Decision follows strong stand on suspending marketing of all drugs prohibited for sale in other countries, including the US, UK, EU and Australia
  4. Watson-Marlow debuts DriveSure OEM pump solution at ACHEMA 2024 The company will showcase solutions suitable for the demands of laboratories, cleanrooms and process environments, including valves, pumps and fill/finish systems
  5. You need to be a subscriber to read this article.
    Click here to find out more.
    Pre-filled syringes: trends and tips from the experts Pre-filled syringes have become a major growth market, but the delivery format does not come free of challenges or competition. Susan Birks reports on the trends and developments discussed at the recent SMi Pre-filled Syringes Conference, held in London

Relevant companies

See more

Upcoming event

BIO International Convention Digital

3-6 June, 2024 | Convention | San Diego, US See all

You may also like

Sustainability

Almac Group signs virtual power purchase agreement for renewable energy

The integration of renewable energy will cut the company’s global scope 2 carbon emissions by 46%
Sustainability

The future of C-14 environmental tracing

Environmental tracing using Carbon-14 (C-14) is a powerful method of studying the movement and degradation of organic compounds in various ecosystems. The technique has become a vital way to understand the dynamics of carbon cycling and the fate of pollutants in the environment
Manufacturing

Almac Pharma Services to showcase high potent processing solutions at Manufacturing Chemist Live

Almac Pharma Services’ VP Operations & Charnwood Site Head, James Hurst, will join the event’s expert line up of speakers and share insight into developing a framework for the design of contained high potent solid oral dose processes
Research & Development

Towards the enzymatic synthesis of oligonucleotides: part II

By early 2020, ten oligonucleotide drugs had received US FDA regulatory approval; with many more in the pipeline, it’s only fair to say that this drug class is becoming big business
Research & Development

Towards the enzymatic synthesis of oligonucleotides: part I

By early 2020, ten oligonucleotide drugs had received US FDA regulatory approval; with many more in the pipeline, it’s only fair to say that this drug class is becoming big business
Research & Development

Almac Group welcomes COVID-19 vaccine trial news from Pfizer and BioNTech

Almac Clinical Services supports BioNTech by performing a range of services including secondary labelling, storage, distribution, provision of depots, temperature management through its TempEZ platform
Analysis

Almac adds biologics testing to analytical suite

The announcement follows the company’s expansion of its Irish laboratory in 2019
Subscribe now